Form D · Other
Tithon Animal Sciences, Inc.
San Diego, CA · CIK 0001699733
Offering snapshot reported Mar 3, 2017 · SEC filing
- Reported sold
- Yet to sell Offering amount: $2.5M
- Investors reported
- 0 Form D · investor count
- Minimum accepted
- $25K Reported outside-investor minimum
- First sale
- Yet to occur As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Mar 3, 2017 | Initial | Yet to sell | No comparison | 0 | SEC filing |
Offering details
- Securities
- Debt, Option to acquire, Security to be acquired
- Exemptions
- 06c
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-281798
Source: Form D, filed Mar 3, 2017. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| George Kolios | Executive |
| Mark Kyle | Director, Executive |
| Peter Milonas | Director, Executive |
| Vasilis Paspaliaris | Director, Executive |
| Richard Schmidt | Executive |
| David Strawn | Executive |
Issuer details
Industry: Other (See others in industry)
Address:
11440 West Bernardo Drive
San Diego, CA, 92029
San Diego, CA, 92029